Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?

OBJECTIVES This review stated the possible application of the active components of licorice, glycyrrhizin (GL) and glycyrrhetinic acid (GA), in rheumatoid arthritis (RA) treatment based on the cyclooxygenase (COX)-2/thromboxane A2 (TxA2) pathway. METHODS The extensive literature from inception to July 2015 was searched in PubMed central, and relevant reports were identified according to the purpose of this study. RESULTS The active components of licorice GL and GA exert the potential anti-inflammatory effects through, at least in part, suppressing COX-2 and its downstream product TxA2. Additionally, the COX-2/TxA2 pathway, an auto-regulatory feedback loop, has been recently found to be a crucial mechanism underlying the pathogenesis of RA. However, TxA2 is neither the pharmacological target of non-steroidal anti-inflammatory drugs (NSAIDs) nor the target of disease modifying anti-rheumatic drugs (DMARDs), and the limitations and side effects of those drugs may be, at least in part, attributable to lack of the effects on the COX-2/TxA2 pathway. Therefore, GL and GA capable of targeting this pathway hold the potential as a novel add-on therapy in therapeutic strategy, which is supported by several bench experiments. CONCLUSIONS The active components of licorice, GL and GA, could not only potentiate the therapeutic effects but also decrease the adverse effects of NSAIDs or DMARDs through suppressing the COX-2/TxA2 pathway during treatment course of RA.

[1]  S. Lim,et al.  Dehydroglyasperin C suppresses TPA‐induced cell transformation through direct inhibition of MKK4 and PI3K , 2016, Molecular carcinogenesis.

[2]  R. Behrouz,et al.  Prevention of Stroke in Rheumatoid Arthritis , 2015, Current Neurology and Neuroscience Reports.

[3]  Ling Meng,et al.  Analysis of patents on anti-rheumatoid arthritis therapies issued in China , 2015, Expert opinion on therapeutic patents.

[4]  Shuai Ji,et al.  Separation and characterization of phenolic compounds and triterpenoid saponins in licorice (Glycyrrhiza uralensis) using mobile phase-dependent reversed-phase×reversed-phase comprehensive two-dimensional liquid chromatography coupled with mass spectrometry. , 2015, Journal of chromatography. A.

[5]  Huji Xu,et al.  Management of rheumatoid arthritis in People’s Republic of China – focus on tocilizumab and patient considerations , 2015, International journal of general medicine.

[6]  J. Smolen,et al.  Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges , 2015, Nature Reviews Rheumatology.

[7]  A. Wakhlu,et al.  Is non-biological treatment of rheumatoid arthritis as good as biologics? , 2015, World journal of orthopedics.

[8]  M. González-Gay,et al.  Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management , 2015, BioMed research international.

[9]  Jong-Eun Kim,et al.  Licochalcone A, a Polyphenol Present in Licorice, Suppresses UV-Induced COX-2 Expression by Targeting PI3K, MEK1, and B-Raf , 2015, International journal of molecular sciences.

[10]  Lin Zhao,et al.  Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs , 2015, Oncotarget.

[11]  Yuqing Xiong,et al.  Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth , 2014, Oncotarget.

[12]  Wen-Chang Chang,et al.  Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation , 2014, Oncotarget.

[13]  Runyue Huang,et al.  Determination of role of thromboxane A2 in rheumatoid arthritis. , 2015, Discovery medicine.

[14]  A. Nagy,et al.  Nimesulide Improves the Symptomatic and Disease Modifying Effects of Leflunomide in Collagen Induced Arthritis , 2014, PloS one.

[15]  Runyue Huang,et al.  The cyclooxygenase-2/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer? , 2014, Cancer letters.

[16]  Runyue Huang,et al.  18β-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer , 2014, PloS one.

[17]  Yijing Su,et al.  Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats. , 2014, Journal of ethnopharmacology.

[18]  Runyue Huang,et al.  Glycyrrhizin Suppresses Lung Adenocarcinoma Cell Growth Through Inhibition of Thromboxane Synthase , 2014, Cellular Physiology and Biochemistry.

[19]  H. Yoshikawa,et al.  Celecoxib, a selective cyclooxygenase‐2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis , 2014, International journal of rheumatic diseases.

[20]  S. Byers,et al.  Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies , 2013, Oncotarget.

[21]  Runyue Huang,et al.  Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells , 2014, Journal of Cancer Research and Clinical Oncology.

[22]  M. Underwood,et al.  Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway. , 2013, Journal of molecular cell biology.

[23]  S. Chuang,et al.  Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells. , 2013, Oncology Report.

[24]  P. Jakobsson,et al.  IL-1β/HMGB1 Complexes Promote The PGE2 Biosynthesis Pathway in Synovial Fibroblasts , 2013, Scandinavian journal of immunology.

[25]  S. Lai,et al.  Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors , 2013, Journal of Gastroenterology.

[26]  Cindy L H Yang,et al.  Scientific Basis of Botanical Medicine as Alternative Remedies for Rheumatoid Arthritis , 2013, Clinical Reviews in Allergy & Immunology.

[27]  K. Dao,et al.  Malignancy risks with biologic therapies. , 2012, Rheumatic diseases clinics of North America.

[28]  H. Zhang,et al.  [Effect of glycyrrhetinic acid on the expression of inflammatory factors in fibroblast-like synovial cells from collagen induced arthritis rats]. , 2012, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[29]  S. Naqvi,et al.  Itraconazole: its possible role in inhibiting angiogenesis in rheumatoid arthritis. , 2012, Medical hypotheses.

[30]  Yao Yao,et al.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid. , 2012, Current therapeutic research, clinical and experimental.

[31]  E. Ingelsson,et al.  Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib. , 2012, European heart journal.

[32]  Runyue Huang,et al.  Cigarette smoking, cyclooxygenase-2 pathway and cancer. , 2011, Biochimica et biophysica acta.

[33]  M. Underwood,et al.  4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor , 2011, Oncogene.

[34]  F. Colbatzky,et al.  Inhibition of cyclooxygenase‐2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in rats , 2011, British journal of pharmacology.

[35]  Tao Jiang,et al.  Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression. , 2011, The Journal of surgical research.

[36]  F. Santilli,et al.  Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. , 2010, Free radical biology & medicine.

[37]  L. Leung,et al.  The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. , 2010, Planta medica.

[38]  P. Sarzi-Puttini,et al.  Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis: An Observational Study , 2010, Clinical reviews in allergy & immunology.

[39]  K. O'Byrne,et al.  The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer. , 2010, Biochimica et biophysica acta.

[40]  S. Lim,et al.  Anti-Inflammatory Effects of Licorice and Roasted Licorice Extracts on TPA-Induced Acute Inflammation and Collagen-Induced Arthritis in Mice , 2010, Journal of biomedicine & biotechnology.

[41]  S. Prescott,et al.  Can licorice lick colon cancer? , 2009, The Journal of clinical investigation.

[42]  Xiwu Chen,et al.  Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. , 2009, The Journal of clinical investigation.

[43]  Sabine S. Lange,et al.  High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage , 2008, Proceedings of the National Academy of Sciences.

[44]  N. Nakahata Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. , 2008, Pharmacology & therapeutics.

[45]  S. Shakir,et al.  Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users , 2008, Drug safety.

[46]  G. Joshi,et al.  Cardiovascular Thromboembolic Adverse Effects Associated with Cyclooxygenase-2 Selective Inhibitors and Nonselective Antiinflammatory Drugs , 2007, Anesthesia and analgesia.

[47]  Yeong Shik Kim,et al.  Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. , 2007, Biological & pharmaceutical bulletin.

[48]  M. Zamai,et al.  Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. , 2007, Chemistry & biology.

[49]  Cheng Lu,et al.  Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis. , 2007, Planta medica.

[50]  A. Bansal,et al.  New Dosage Formulations for Targeted Delivery of Cyclo-Oxygenase-2 Inhibitors , 2007, Drugs & aging.

[51]  E. MacLaughlin,et al.  Cyclooxygenase-2 inhibitors: a painful lesson. , 2006, Cardiovascular & hematological disorders drug targets.

[52]  D. Gemsa,et al.  The influence of synovial fluid exudates from patients with rheumatoid arthritis on the proliferation of peripheral blood lymphocytes and the prostanoid release from monocytes , 1981, Agents and Actions.

[53]  F. Burdan,et al.  [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy]. , 2003, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[54]  F. Burdan,et al.  [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects]. , 2003, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[55]  E. Meagher Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors , 2003, Drug safety.

[56]  T. Hishinuma,et al.  Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[57]  D. Nixon,et al.  Licorice and Cancer , 2001, Nutrition and cancer.

[58]  D. Barros,et al.  Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. , 2000, Rheumatology.

[59]  D. Spray,et al.  Inhibition of Endothelial Cell Migration, Intercellular Communication, and Vascular Tube Formation by Thromboxane A2 * , 1999, The Journal of Biological Chemistry.

[60]  W. Craig Health-promoting properties of common herbs. , 1999, The American journal of clinical nutrition.

[61]  K. Kobashi,et al.  Bioavailability Study of Glycyrrhetic Acid after Oral Administration of Glycyrrhizin in Rats; Relevance to the Intestinal Bacterial Hydrolysis , 1996, The Journal of pharmacy and pharmacology.

[62]  M. Seitz,et al.  Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. , 1985, Annals of the rheumatic diseases.

[63]  J. Salmon,et al.  Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture , 1983, Annals of the rheumatic diseases.

[64]  F. Blotman,et al.  PGE2, PGF2 alpha, and TXB2 biosynthesis by human rheumatoid synovia. , 1980, Advances in prostaglandin and thromboxane research.